ATOSSA THERAPEUTICS, INC. — Form 10-Q
Filed August 7, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 2/100
What the filing says
This is a Form 10-Q quarterly report filed on 2026-08-07 for the period ending 2026-06-30. The filing header does not contain financial statements, operational results, or material events—only document metadata, company registration details (CIK 0001488039, DE incorporation, Seattle WA address), and SIC code 2834 (Pharmaceutical Preparations). The actual 10-Q content (document 1, atos-20260630.htm) is referenced but not provided in this excerpt.
Why this rating
Header-only excerpt; no financial data, transactions, guidance changes, or material events disclosed. Substance unknown.
See more from August 7, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.